Impact of cytochrome P450 genes on suicide attempt and risk

被引：3
作者：
Penas-Lledo, Eva M. [1 ,2 ,3 ]
Naranjo, M. Eugenia G. [1 ,2 ]
LLerena, Adrian [1 ,2 ]
机构：
[1] Extremadura Univ Hosp, Sch Med, CICAB Clin Res Ctr, Badajoz, Spain
[2] CIBERSAM, Badajoz, Spain
[3] Univ Extremadura, Sch Med, E-06080 Badajoz, Spain
来源：
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE | 2013年 / 263卷 / 08期
关键词：
CYP2D6; GENES; CYP2C19; CYP1A2;
D O I：
10.1007/s00406-013-0402-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：703 / 704
页数：2
相关论文
共 8 条
  • [1] The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder
    Hoefer, Peter
    Schosser, Alexandra
    Calati, Raffaella
    Serretti, Alessandro
    Massat, Isabelle
    Kocabas, Neslihan Aygun
    Konstantinidis, Anastasios
    Linotte, Sylvie
    Mendlewicz, Julien
    Souery, Daniel
    Zohar, Joseph
    Juven-Wetzler, Alzbeta
    Montgomery, Stuart
    Kasper, Siegfried
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2013, 263 (05) : 385 - 391
  • [2] CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
    LLerena, A.
    Dorado, P.
    Ramirez, R.
    Gonzalez, I.
    Alvarez, M.
    Penas-LLedo, E. M.
    Perez, B.
    Calzadilla, L. R.
    [J]. PHARMACOGENOMICS JOURNAL, 2012, 12 (02) : 176 - 183
  • [3] CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients (vol 18, pg 266, 2013)
    Penas-LLedo, E. M.
    Trejo, H. D.
    Dorado, P.
    Ortega, A.
    Jung, H.
    Alonso, E.
    Naranjo, M. E. G.
    Lopez-Lopez, M.
    LLerena, A.
    [J]. MOLECULAR PSYCHIATRY, 2013, 18 (02) : 266 - 266
  • [4] High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders
    Penas-LLedo, E. M.
    Dorado, P.
    Agueera, Z.
    Gratacos, M.
    Estivill, X.
    Fernandez-Aranda, F.
    LLerena, A.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (07) : 691 - 692
  • [5] Peñas-Lledó EM, 2012, PHARMACOGENOMICS, V13, P179, DOI [10.2217/PGS.11.146, 10.2217/pgs.11.146]
  • [6] Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients
    Serretti, Alessandro
    Calati, Raffaella
    Massat, Isabelle
    Linotte, Sylvie
    Kasper, Siegfried
    Lecrubier, Yves
    Sens-Espel, Roser
    Bollen, Joseph
    Zohar, Joseph
    Berlo, Jacques
    Lienard, Patricia
    De Ronchi, Diana
    Mendlewicz, Julien
    Souery, Daniel
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (05) : 250 - 256
  • [7] CYP2D6 in the Brain: Impact on Suicidality
    Stingl, J. C.
    Viviani, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 352 - 353
  • [8] High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases
    Zackrisson, A. L.
    Lindblom, B.
    Ahlner, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 354 - 359
1